ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166641 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166641; 2) Community: the network communities that were significantly associated with the response to NSC 166641; 3) Molecule: the relationships between components within communities and NSC 166641; 4) MDR: the compounds that were significantly associated with the NSC 166641.

NSC Compound Enrichment Correlation
NSC 329261 Null 0.00526022686151168 0.18354141
NSC 40273 Null 0.00526022686151168 0.16415707
NSC 606172 Camptothecin Derivative 0.00526022686151168 0.60163085
NSC 613327 Gemcitabine Y 0.00526022686151168 0.58176985
NSC 616348 Irinotecan hydrochloride 0.00526022686151168 0.56554487
NSC 646127 6H-Pyrido[4,3-b]carbazole, 1,2-dihydro-2,5,9,11-tetra- methyl- 0.00526022686151168 -0.013157798
NSC 647117 Null 0.00526022686151168 0.29975103
NSC 665759 Null 0.00526022686151168 0.17694762
NSC 678925 1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride 0.00526022686151168 0.50070587
NSC 681636 Camptothecin Derivative 0.00526022686151168 0.4587846
Total:106  Current:19    [First] [Prev] [Next] [Last]